OR (95 % CI) | p-value | |
---|---|---|
Clinical factors | ||
Male vs. Female | 0.416 (0.150–1.155) | 0.092 |
Body weight | 1.008 (0.963–1.054) | 0.741 |
Age | 0.972 (0.914–1.034) | 0.366 |
Clinical Size | 1.061 (0.992–1.136) | 0.085 |
Subsolid type vs. Solid type | 2.683 (0.868–8.295) | 0.087 |
3D-IRA | 0.956 (0.930–0.983) | 0.002 |
Corrected 3D-IRA | 0.721 (0.595–0.873) | <0.001 |
Pathological factors | ||
Others as compared to adenocarcinoma | 1.078 (0.261–4.456) | 0.918 |
Pathological size | 1.139 (1.038–1.251) | 0.006 |
Differentiation grade | 2.521 (1.177–5.398) | 0.017 |